Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2475 of 2529 entries
View as:

Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05739942 Org: User:
Start: 05/15/24 End: 08/28/31 Due: 08/28/32

A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT05230537 Org: User:
Start: 02/17/22 End: 10/12/26 Due: 10/12/27

An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.

Phase: N/A Priority: Normal
NCT ID: NCT03909295 Org: User:
Start: 05/07/19 End: 11/19/19 Due: 11/19/20

Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients With Chronic Heart Failure

Phase: N/A Priority: Normal
NCT ID: NCT05870709 Org: User:
Start: 05/15/23 End: 10/31/24 Due: 10/31/25

Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT00877383 Org: User:
Start: 04/30/09 End: 02/28/10 Due: 02/28/11

Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF)

Phase: N/A Priority: Normal
NCT ID: NCT02389933 Org: User:
Start: - End: - Due: -

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls.

Phase: N/A Priority: Normal
NCT ID: NCT05084638 Org: User:
Start: 01/25/22 End: 02/16/26 Due: 02/16/27

Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT03804879 Org: User:
Start: 12/17/18 End: 05/03/21 Due: 05/03/22

Phase I Study of PDR001 in Patients With Advanced Malignancies.

Phase: N/A Priority: Normal
NCT ID: NCT02678260 Org: User:
Start: 02/19/16 End: 09/01/17 Due: 09/01/18

This is a Two-year Follow-up Study to Evaluate the Long-term Safety, Tolerability and Efficacy of 2 Different Doses of Everolimus

Phase: N/A Priority: Normal
NCT ID: NCT00531063 Org: User:
Start: 11/30/01 End: - Due: -

A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00099905 Org: User:
Start: 04/30/04 End: 10/31/05 Due: 10/31/06

The Effects of a Single Intravenous Administration of Secukinumab (AIN457) or Canakinumab (ACZ885) in Dry Eye Patients

Phase: N/A Priority: Normal
NCT ID: NCT01250171 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03701334 Org: User:
Start: 12/07/18 End: 05/29/26 Due: 05/29/27

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00329940 Org: User:
Start: 11/30/05 End: - Due: -

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

Phase: N/A Priority: Normal
NCT ID: NCT06868212 Org: User:
Start: 07/25/25 End: 08/23/27 Due: 08/23/28

Assessment of the Quality of Life of Multiple Sclerosis Patients Treated With Ofatumumab in Real-life in France

Phase: N/A Priority: Normal
NCT ID: NCT06157086 Org: User:
Start: 12/21/23 End: 07/31/26 Due: 07/31/27

Everolimus Plus Best Supportive Care vs Placebo Plus Best Supportive Care in the Treatment of Patients With Advanced Neuroendocrine Tumors (GI or Lung Origin)

Phase: N/A Priority: Normal
NCT ID: NCT01524783 Org: User:
Start: 03/30/12 End: 08/07/20 Due: 08/07/21

Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01302886 Org: User:
Start: 05/31/11 End: 11/30/13 Due: 11/30/14

Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study)

Phase: N/A Priority: Normal
NCT ID: NCT01279473 Org: User:
Start: 08/31/05 End: - Due: -

The Efficacy Study of Aclasta on Prosthetic Fixation in Postmenopausal Women After THA

Phase: N/A Priority: Normal
NCT ID: NCT02333344 Org: User:
Start: 07/30/15 End: 01/28/20 Due: 01/28/21

Lapatinib and Bevacizumab for Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00444535 Org: User:
Start: 02/27/07 End: 06/19/20 Due: 06/19/21

An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT00171210 Org: User:
Start: 10/31/04 End: - Due: -

Study of Efficacy and Safety of Ociperlimab in Combination With Tislelizumab and Platinum-based Doublet Chemotherapy as First-line Treatment for Participants With Locally Advanced or Metastatic NSCLC.

Phase: N/A Priority: Normal
NCT ID: NCT05791097 Org: User:
Start: 07/28/23 End: 12/26/27 Due: 12/26/28

Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03517540 Org: User:
Start: 09/11/18 End: 10/15/20 Due: 10/15/21

Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT00396071 Org: User:
Start: 10/31/06 End: - Due: -